-
Ferring appoints President of the Ferring Research Institute
in PRESS RELEASE 2004 onFerring, a biopharmaceutical company with its headquarters in Lausanne, Switzerland announced today that Dr. John L. McGuire has been appointed as the President of the Ferring Research Institute…
-
Dr Eberhard Zinn, Ferring Board Member, dies at 66
in PRESS RELEASE 2004 onFerring founding board member, Dr. Eberhard Zinn died last week; he was 66 years old…
-
Research by 2003 Nobel Laureate in Chemistry Fills in ‘Scientific Gaps’ Necessary for Ferring Researchers to Develop Incontinence Product Focusing on the Kidney
in PRESS RELEASE 2004 onFerring is exploring the links between recent Nobel Prize winning…
-
Updates in Infertility Congress
in PRESS RELEASE 2004 onInfertility experts from around the world gather to review the newest breakthroughs including…
-
Additional data for MENOPUR* (HP-hMG)
in PRESS RELEASE 2004 onThe new data was based on a sub-analysis of the landmark trial EISG (European-Israeli Study Group) which was designed to demonstrate non-inferiority of MENOPUR (HP-hMG) when compared with rFSH in nearly 700 IVF and ICSI patients…
-
Ferring Acquires DUPOMAR
in PRESS RELEASE 2004 onThe acquisition reinforces Ferring’s commitment to Latin America and strengthens the company in the field of women’s health…
-
Ferring Acquires NORPROLAC
in PRESS RELEASE 2004 onFerring announced today the closing of a deal with Novartis Pharma AG for the acquisition of the worldwide manufacturing, marketing and distribution rights of NORPROLAC (quinagolide)…
PRESS RELEASE 2004
PRESS RELEASE 2004
